분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2018-10-04 11:25:53 , Hit : 345
 Frances H. Arnold, George P. Smith, and Gregory P. Winter share 2018 Nobel Prize in Chemistry

https://cen.acs.org/biological-chemistry/Frances-H-Arnold-George-P-Smith-and-Gregory-P-Winter-share-2018-Nobel-Prize-in-Chemistry/96/web/2018/10?utm_source=NonMember&utm_medium=Newsletter&utm_campaign=CEN

Trio recognized for harnessing evolution to identify new enzymes and binding proteins

by  Celia Henry Arnaud  


October 3, 2018


he 2018 Nobel Prize in Chemistry was awarded to Frances H. Arnold of California Institute of Technology for the directed evolution of enzymes and to George P. Smith of the University of Missouri and Gregory P. Winter of the MRC Laboratory of Molecular Biology for the phage display of peptides and antibodies. Arnold will receive half of the approximately $1 million prize; Smith and Winter will split the other half equally.


This year’s prize “recognizes the power of harnessing protein evolution to solve a wide range of problems in the molecular sciences,” says David R. Liu of Harvard University, who has developed a version of directed evolution called phage-assisted directed evolution. “My hat’s off to Smith, Winter, and Arnold for their contributions to this multidisciplinary field that beautifully integrates chemistry, molecular biology, and protein science.”


Directed evolution is an iterative lab method involving mutation and screening that speeds up the natural selection process through which life on Earth evolved. In Arnold’s technique, she introduces random mutations into the gene for a starting enzyme, expresses the variant genes in bacteria, and screens the mutated enzymes produced by the microbes for desired activity. By repeating this process with the best performers, researchers can find proteins with the desired enzymatic properties in terms of activity, binding affinity, or specificity.


Arnold conducted the first directed evolution of enzymes in 1993. In that work, she evolved a version of the enzyme subtilisin E that was active at high concentrations of the polar organic solvent dimethylformamide. Four rounds of mutagenesis and screening resulted in an enzyme that was 256 times as active as the original enzyme.




Sign up for C&EN's must-read weekly newsletter



      
  
Subscribe »



Contact us  to opt out anytime
  
  

Smith reported the original phage display method in 1985. In this library-based method for screening for proteins that bind a specific molecule, the gene for each member of the library is inserted in the DNA for coat protein III of phage, a virus that infects bacteria. The phage infects and reproduces in bacteria. Scientists can then use the target molecule as bait to enrich phages released by the bacteria that have the binding protein of interest on their surface.


Sequencing the genetic material of the collected phages yields genes for proteins with desired binding affinity.


Winter extended phage display to screening for novel antibodies. In 1990, Winter’s team reported the phage display of a folded and fully functional antibody fragment called a single-chain variable fragment. This first demonstration identified selective antibodies that could bind hen egg-white lysozyme but not human lysozyme or turkey egg-white lysozyme.


Directed evolution and phage display have both become widely used methods. C&EN featured Provivi, a company founded by Arnold and two of her coworkers, in its 10 Start-ups to Watch in 2015. Provivi uses enzymes developed through directed evolution to make insect pheromones for pest control. And researchers have used phage display to identify antibodies with high binding affinity for use as pharmaceuticals. The first approved drug developed using phage display is Abbvie’s Humira (adalimumab), which was approved by the U.S. Food & Drug Administration in 2002.




Advertisement




“This is a fantastic award that recognizes how laboratory evolution, in a few short decades, has revolutionized our ability to tailor the properties of biomolecules for applications unimagined in nature,” says Donald Hilvert, an expert in directed evolution at the Swiss Federal Institute of Technology, Zurich.


Commenting on the biological flavor of this year’s chemistry Nobel, Peter K. Dorhout, president of the American Chemical Society, says, “This is chemistry. Chemistry is broad and deep. In the case of evolved enzymes, it’s catalytic chemistry and organic chemistry. To develop and understand the critical tools to evaluate how cells behave is also fundamental analytical chemistry.”







1267   [바이오토픽] CRISPR 특허전쟁 항소심, 브로드 연구소 승리  이성욱 2018/09/11 244
1266   Lethal Viruses Hijack DNA-Damage Response, May Be Exploited for Cancer  이성욱 2018/08/07 258
1265   Ruling on gene editing crops a threat to innovation and future food security, scientists say  이성욱 2018/07/28 263
1264   Lenvima OK'd as First-Line Treatment for Unresectable Hepatocellular Carcinoma  이성욱 2018/08/19 269
1263   CRISPR-Cas12a More Precise Than CRISPR-Cas9  이성욱 2018/08/07 281
1262   Doubts arise again about CRISR'd human embryos  이성욱 2018/08/09 284
1261   RNA World May Have Started Spinning with Triplet-Based Synthesis  이성욱 2018/05/21 293
1260   [바이오토픽] 유전자를 침묵시키는 신약, 20년의 기다림 끝에 승인  이성욱 2018/08/13 297
1259   Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements  이성욱 2018/07/17 298
1258   Gene Therapy Ever More Common for Rare Disorders  이성욱 2018/05/30 329
1257   CRISPR Efficiency Tied to Cancer-Causing Process  이성욱 2018/06/13 329
  Frances H. Arnold, George P. Smith, and Gregory P. Winter share 2018 Nobel Prize in Chemistry  이성욱 2018/10/04 345
1255   RNA-Based Gene Therapy Can Be Turned ON or OFF via Synbio Switches  이성욱 2018/10/18 350
1254   Keytruda Gets FDA Approval for Hepatocellular Carcinoma  이성욱 2018/11/14 350
1253   Cause of CRISPR Failure Identified and Reversed  이성욱 2018/07/12 354
1252   Novel Two-Pronged Method Targets Cancer Cells’ Telomerase and Chromosomes  이성욱 2018/11/03 359
1251   Immunotherapy Pioneers Take 2018 Nobel Prize  이성욱 2018/10/02 365
1250   Spark Therapeutics shares rise on FDA approval of new gene therapy for blindness  이성욱 2017/12/20 370
1249   Checkpoint Inhibitor Generated by Synthetic DNA in Vivo  이성욱 2018/10/06 372
1248   분자수준 인체 간세포 지도 처음 작성  이성욱 2018/10/24 373

1 [2][3][4][5][6][7][8][9][10]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN